CRP tests and patient leaflets to reduce antibiotics for adults with respiratory infections in Kyrgyzstan
Official title: CRP and Patient Information Leaflets to Optimise Antibiotic Treatments for Adults With Respiratory Tract Infections in Primary Care in Kyrgyzstan
Run by Copenhagen University Hospital, Rigshospitalet · NCT07261969 · Data updated 2026-11-12
This project will test whether using quick CRP blood tests and easy-to-read patient information leaflets helps doctors in Kyrgyzstan prescribe fewer antibiotics for adults with recent respiratory symptoms.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 70 Years |
| Sex | All |
| Enrollment | 1050 (estimated) |
| Sponsor | Copenhagen University Hospital, Rigshospitalet Academic / other |
| Locations | 2 sites (Sokuluk Village, Chui Region and 1 other locations) |
| Status | Recruiting |
| Started | December 18, 2024 |
| Main results expected | March 30, 2026 |
| Study ends | April 30, 2027 |
| Registry record updated | December 3, 2025 |
| Trial ID | NCT07261969 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults aged 18–70 presenting to participating primary care centers with acute respiratory symptoms of less than two weeks who can give informed consent and complete follow-up are ideal candidates.
✕Probably not a fit
Patients who are severely ill or need urgent referral, are immunosuppressed, pregnant, recently on antibiotics, or cannot complete follow-up are unlikely to benefit from this intervention.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This multicentre, open-label randomized trial will enroll adults (18–70) with acute respiratory symptoms at 14 rural and one urban primary care centres in Kyrgyzstan. Participants are randomized in a 2x3 design: patient information leaflet versus no leaflet, and one of three CRP point-of-care test thresholds (20, 40, or 60 mg/L), creating six groups. Clinicians will use CRP results and the leaflet allocation to guide antibiotic prescribing, with 21 days of blinded follow-up to monitor antibiotic use, clinical recovery, and safety. Primary outcomes include antibiotic prescribing and patient safety, and secondary outcomes include reconsultations and symptom duration.
Why it matters
Potential benefit: If successful, the approach could safely reduce unnecessary antibiotic prescriptions and help curb antimicrobial resistance in Kyrgyz primary care.
How similar studies have gone: Previous work, including the COORDINATE trial, showed CRP point-of-care testing can reduce antibiotic use without compromising safety, but the best CRP cut-offs for adults remain unproven.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Adults aged 18 to 70 years with ARTI according to the attending HCW; * Having at least one of the following respiratory symptoms lasting for less than 2 weeks (with or without a fever): * cough; * shortness of breath; * sore throat; * stuffy nose; * wheezing. * Able and willing to comply with all study requirements. * Able and willing to give informed consent. Exclusion Criteria: * Severely ill and in need of urgent referral where measurement of POCT CRP is not relevant or would delay the process; * Terminally ill patients; * Patients with known immunosuppression or severe chronic disease (HIV, liver failure, kidney failure, history of neoplastic disease, long term systemic steroid use or similar conditions as assessed by the health worker or research team); * Patients who are not able to participate in follow-up procedures (lack of telephone etc.); * Have taken antibiotics within 24 hours before the index consultation; * Pregnant women; * Unable or unwilling to provide informed consent.
Where it's running
-
Sokuluk Family Medicine Center
Sokuluk Village, Chui Region, Kyrgyzstan Recruiting -
Azim Azhybek uulu
At-Bashy Village, Naryn Region, Kyrgyzstan Recruiting
Study contacts
- Study coordinator: Azamat Akylbekov, MD
- Email: azamatti@yahoo.com
- Phone: +996700351748
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Optimizing pulse (beans, lentils, peas) intake for cardiometabolic health
We will test whether eating 1.5 or 3 cups of pulses each week helps adults who currently eat less than 1.5 cups/week improve cholesterol, inflammation, blood sugar, and blood pressure.
-
Evaluating the CALLY Index for Predicting Delirium After Hip Surgery in Older Patients
This study is testing if a new index can help predict delirium in older patients after they have hip surgery.
-
Predicting Heart Muscle Recovery After CTO Revascularization
This study looks at whether blood tests and stress echo measurements can predict which patients with CTO will regain heart muscle function after a revascularization procedure.
-
Collagen and omega-3 supplements in middle-aged women
This study tests whether taking collagen and omega-3s together improves joint pain, fatigue, sleep, and overall wellbeing in healthy women aged 35–65 compared with a placebo over 8 weeks.
-
Creatine or placebo to test effects on cognition, muscle strength, and body composition in middle-aged women
This study tests whether taking creatine daily for 8 weeks improves thinking, strength, fatigue, and body composition in healthy middle-aged women compared to a placebo.
-
How common dietary fats change gut bacteria and metabolic markers
We will test whether replacing part of daily fat with butter, coconut oil, olive oil, or sunflower oil for two weeks changes gut bacteria and related blood markers in healthy adults aged 20–50.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.